Merck CEO: Antiviral pill could make Covid manageable

Merck is set to acquire Acceleron Pharma for $180 a share. CNBC's Meg Tirrell spoke with Robert Davis, Merck CEO and president, about the upcoming data regarding the company's new Covid antiviral pill and the Merck-Acceleron Pharma deal.